Integrated Analysis of Two Phase 2 Trials of Nivolumab in Metastatic Rare Solid Cancer with Dmmr or Pmmr (MASTER KEY Sub-Studies: ROCK and ROLL Trial).
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2024)